| Product NDC: | 0024-5841 |
| Proprietary Name: | ZALTRAP |
| Non Proprietary Name: | ziv-aflibercept |
| Active Ingredient(s): | 200 mg/8mL & nbsp; ziv-aflibercept |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0024-5841 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125418 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20120803 |
| Package NDC: | 0024-5841-01 |
| Package Description: | 1 VIAL in 1 CARTON (0024-5841-01) > 8 mL in 1 VIAL |
| NDC Code | 0024-5841-01 |
| Proprietary Name | ZALTRAP |
| Package Description | 1 VIAL in 1 CARTON (0024-5841-01) > 8 mL in 1 VIAL |
| Product NDC | 0024-5841 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ziv-aflibercept |
| Dosage Form Name | SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120803 |
| Marketing Category Name | BLA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | ZIV-AFLIBERCEPT |
| Strength Number | 200 |
| Strength Unit | mg/8mL |
| Pharmaceutical Classes |